Perimetric Testing With Virtual Reality

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-03

Study Completion Date

2024-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Perimetry is an essential component in the diagnosis and monitoring of glaucoma. Since the advent of Standard Automated Perimetry (SAP), one of the clinical standards has been the Humphrey Field Analyzer (HFA, Carl Zeiss AG, Oberkochen, Germany). Visual field (VF) testing provided by the HFA is standard-of-care in glaucoma clinics and other ophthalmology and optometry practices. However, the HFA is a large device that does not allow for examination outside the clinic and can be uncomfortable for patients with limited mobility.

This study aims to evaluate a novel head-mounted perimeter against the HFA as an alternative method of VF testing. This new perimeter uses a Virtual Reality (VR) headset and a gamified version of VF testing to assess the visual function of healthy eyes and patients. The results of this study will potentially serve as pilot data for the design of a larger study that involves the full assessment of the VR headset and its VF test, based on various testing strategies.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Feasibility, Accuracy, and Reproducibility of Virtual Reality Visual Field Testing in Patients With Glaucoma

NCT07063537

Glaucoma Open-Angle

RECRUITING NA

Evaluating Home Testing Devices for the Management of Glaucoma

NCT05325996

Glaucoma, Open-Angle

COMPLETED NA

Persistence of Glaucoma Patients With Web-Browser-Based Visual Field Test

NCT05690152

Glaucoma

WITHDRAWN NA

Glaucoma Screening

NCT06186388

Glaucoma

COMPLETED NA

Evaluation of a Novel Head-Mounted Device for Glaucoma Testing: A Proof-of-Concept Study

NCT05030714

Glaucoma

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Procedures:

1. Ophthalmic screening:

(a) Visual acuity, slit lamp exam, rebound tonometry (all subjects)
2. OCT examination of the study eye with the Topcon Maestro2 Optical Coherence Tomography (OCT):

(a) Standard Retinal Nerve Fiber Layer (RNFL), Optic Disc and Ganglion Cell Complex (GCC) scan patterns (i) Fundus photo is automatically obtained. (b) Abnormalities consistent with ophthalmic disease will be an exclusion for the healthy group of subjects. Reasonable and common artifacts that do not significantly impair the scan report will be accepted.

(c) OCT abnormalities consistent with glaucoma are expected on the 30 glaucoma subjects.
3. Once eligible, each patient will perform four (4) visual field tests:

(a) once with the HFA Swedish Interactive Threshold Algorithm (SITA) Standard 24-2 pattern (i) Reliability criteria: False Positives no higher than 15% (b) three tests with the VR headset: (i) two tests with ZEST strategy (ii) one test with gamified ZEST strategy (c) Counter-balancing will be used to determine the order of (a) and (b). In particular, a study participant will either start with the HFA visual field test and then proceed to the three tests with the VR headset; or, start with the three VR tests and finish with the HFA visual field test. The sequence of the visual field tests for each study ID will be provided by the sponsor.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glaucoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

30 healthy subjects 30 glaucoma subjects

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy subjects

30 healthy subjects

Group Type OTHER

Perimetric test

Intervention Type DIAGNOSTIC_TEST

This study aims to evaluate a novel head-mounted perimeter against the HFA as an alternative method of VF testing. This new perimeter uses a Virtual Reality (VR) headset and a gamified version of VF testing to assess the visual function of healthy eyes and patients.

Glaucoma subjects

30 glaucoma patients, 10 mild, 10 moderate, 10 severe

Group Type OTHER

Perimetric test

Intervention Type DIAGNOSTIC_TEST

This study aims to evaluate a novel head-mounted perimeter against the HFA as an alternative method of VF testing. This new perimeter uses a Virtual Reality (VR) headset and a gamified version of VF testing to assess the visual function of healthy eyes and patients.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Perimetric test

This study aims to evaluate a novel head-mounted perimeter against the HFA as an alternative method of VF testing. This new perimeter uses a Virtual Reality (VR) headset and a gamified version of VF testing to assess the visual function of healthy eyes and patients.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

1. Age range: 25-70 years
2. For normal subjects:

1. Patient is free of any current or prior ophthalmic pathologies that would potentially cause visual field defects: e.g. retina pathology, glaucoma, cataracts, keratoconus
2. No ocular surgery other than cataract surgery within 6 months prior to the study visit
3. For glaucoma subjects:

1. Patient has a diagnosis of primary open-angle glaucoma
2. Patient is free of any other current or prior ophthalmic pathologies that would potentially cause visual field defects.
3. No other ocular surgery other than glaucoma or cataract surgery within 6 months prior to the study visit
4. No IOP lower than 10 mm/Hg or higher than 30 mm/Hg
4. Refractive Error:

1. Sphere = up to -6.00 D to and up +3.00
2. Cylinder = up to -3.00 is common
5. No past refractive eye surgery
6. No Multifocal or phakic (ICLs) IOL; no multifocal CLs
7. One eligible eye
8. Ability to sit for standard VF bowl exam. Ability to wear VR perimetry headset device.

Minimum Eligible Age

25 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes